We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma"), announced today that it intends to offer its ordinary shares in an underwritten public offering.
Shares of Theravance Biopharma were down almost 10% in after-hours trading on Thursday after the company disclosed plans for a public offering of its common stock, as reported by Fidelity.